Recombinant Rat TIM-3 protein (rFc Tag)

Species

Rat

Purity

>90 %, SDS-PAGE

Tag

rFc Tag

Activity

not tested

Cat no : Eg3245

---

Validation Data Gallery

• 

  Purity of Recombinant Rat TIM-3 was determined by SDS-PAGE. The protein was resolved in an SDS-PAGE in reducing (R) and non-reducing (NR) conditions and stained using Coomassie blue.

---

Product Information

• Purity: >90 %, SDS-PAGE
• Endotoxin: <0.1 EU/μg protein, LAL method
• Activity:

  Not tested

• Expression: HEK293-derived Rat TIM-3 protein Leu22-Ala194 (Accession# P0C0K5) with a rabbit IgG Fc tag at the C-terminus.
• GeneID: 363578
• Accession: P0C0K5
• PredictedSize: 45.0 kDa
• SDS-PAGE: 50-70 kDa, reducing (R) conditions
• Formulation: Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
• Reconstitution: Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
• Storage Conditions:
  It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
• Shipping: The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

Background

TIM3, also known as HAVCR2, is a member of the recently discovered T cell Ig and mucin domain-containing molecule superfamily. TIM3 is a negative regulatory molecule that is important for T cell tolerance and has a crucial role in autoimmunity and T cell exhaustion during chronic viral infection. TIM3 is expressed by T-helper type 1 (Th1) cells, macrophage, monocyte, dendritic cells, CD8+ T cell and other lymphocyte subsets. Galectin-9 is a ligand for TIM3. TIM3-galectin-9 pathway negatively regulates T helper type 1 immunity.

References:

1.Sada-Ovalle I, et al. (2012). J Immunol. 15;189(12):5896-902.
2.Zhu C, et al. (2005). Nat Immunol. 6(12):1245-52.
3.Lee MJ, et al. (2009). Immune Netw. 9(2):58-63.
4.van de Weyer PS, et al. (2006). Biochem Biophys Res Commun. 15;351(2):571-6.
5.McIntire JJ, et al. (2001). Nat Immunol. 2(12):1109-16.